“…[7][8][9][10][11] Polymorphisms in the ligand binding sites of both Fc␥RIIA and Fc␥RIIIA, which alter ligand binding and receptor function, are associated with SLE, 12-18 and we have recently described both linkage and association of Fc␥RIIIA locus with SLE in casecontrol and family-based studies. 19 Additional variations in the human Fc␥Rs, such as the stop codon polymorphism in Fc␥RIIC extracellular domain 1, [20][21][22][23] might also play a role in SLE. However, analysis has been hampered by the very high homology among several of these genes, which is most likely the result of duplication and recombination in the evolution of this cluster.…”